Charles River Laboratories International, Inc.
As of Oct 22, 2026 close
- Market cap
- $16.31B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $146.20$333.30
- Volume (live)
- -
- Avg. volume (3M)
- 1.09M
Charles River Laboratories International (CRL) Stock Price & Financial Analysis
Charles River Laboratories International Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $337.78 - $351.21 |
|---|---|
| 52-Week High | $333.30 |
| 52-Week Low | $146.20 |
| Open | $341.43 |
| Volume (last close) | 2.66M |
| Average Volume (3M) | 1.09M |
| Revenue (TTM) | 4.00B |
|---|---|
| Net Income (TTM) | -238.46M |
| Free Cash Flow (TTM) | 370.61M |
| EPS (TTM) | −$4.88 |
| Profit Margin | -5.96% |
| Operating Margin | 12.35% |
| Return on Equity (ROE) | -8.40% |
| Debt to Equity | 0.92 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 16.31B |
|---|---|
| Shares Outstanding | 48.02M |
| Price to Sales (P/S) | 4.08 |
| Price to Book (P/B) | 5.74 |
| EV/EBITDA | 84.99 |
| 50-Day MA | $290.30 |
|---|---|
| 200-Day MA | $216.16 |
| 1-Year Change | +77.86% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Charles River Laboratories International at a Glance
As of the Oct 22, 2026 close, Charles River Laboratories International (CRL) has a market capitalization of $16.31B. The stock trades at 4.1× sales. Over the trailing twelve months it lost $238.46M on revenue of $4.00B and generated $370.61M of free cash flow. Revenue fell 0.7% year over year.
As of its latest reported balance sheet, it holds $192.03M in cash and securities against $2.62B of debt, a net debt position of $2.43B.
Charles River Laboratories International does not currently pay a dividend.
The share price is up 77.9% over the past year. At $339.66 (the Oct 22, 2026 close) it sits near the top of its 52-week range of $146.19 to $333.30, above its 200-day moving average of $216.16.
Based on 16 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $328.00, 3.4% below the Oct 22, 2026 close.
Frequently Asked Questions About Charles River Laboratories International
What is the current stock price for CRL?
As of the Oct 22, 2026 close, CRL stock trades at $339.66. The 52-week range is $146.20–$333.30, with a day range of $337.78–$351.21.
What is the P/E ratio for CRL?
The P/E ratio (Price-to-Earnings) for CRL is shown in the Key Statistics section. This valuation metric helps compare Charles River Laboratories International, Inc. to industry peers.
Does CRL pay dividends?
Charles River Laboratories International does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRL?
Based on ratings from 16 professional analysts over the last 90 days, the consensus for CRL is Buy. The average 12-month price target is $328.00, a 3.4% downside from the Oct 22, 2026 close of $339.66.
What is the market cap of CRL?
As of the Oct 22, 2026 close, Charles River Laboratories International's market capitalization is $16.31B, classifying it as a large-cap company. Charles River Laboratories International operates in the Healthcare sector within the Diagnostics & Research industry.